Research On The Regional Business Integration Of Medium-sized Chain Pharmacies In Liaoning

At present,China is gradually entering the aging society,and the various social medical security systems are gradually improved,and the demand for drug is huge in our country.However,one of the paradox is that the chain management in the pharmaceutical retail industry in our country is not high,and there are a large number of small and medium sized pharmaceutical retail enterprises in the industry.With the increase of market competition and drug prices control tightened by the government,,small and medium sized pharmaceutical sales enterprises are facing very big market pressure.The subject discussed in this paper is the market behavior strategy of medium-sized pharmaceutical enterprises.In the course of the discussion,the article compares the market situation of developed countries such as the United States and Japan,and analyzes the possibility of horizontal expansion and vertical expansion.The final conclusion is that horizontal expansion is a safer behavior strategy for pharmaceutical enterprises.But the next question is the traditional modes of mergers and acquisitions horizontal expansion,medium-sized pharmaceutical enterprises also face many practical difficulties.Therefore,based on the characteristics of enterprises,combining practical work experience,a complete platform integration scheme should be developed for medium-sized pharmaceutical enterprises.The project adopts the modern enterprise system model,and it has organized a relatively independent form of alliance among the members through a predetermined arrangement,that is,platform companies.Under the platform company,all medium-sized pharmaceutical sales enterprises can maintain independence and enjoy the scale effect brought by platform companies.Finally,in view of the integration program,the paper tries to put forward some safeguards.